By the Corex Vitality™ Research Team · Last checked 9 November 2026 · Sources listed under Published Research
Quick summary
- CJC-1295 and ipamorelin are two separate peptides. They are often named together, but they are not one molecule.
- CJC-1295 (no DAC), also called Mod GRF (1-29), has 29 amino acids and is studied at the GHRH receptor.
- Ipamorelin has 5 amino acids (a pentapeptide) and is studied at the ghrelin receptor (GHS-R1a).
- Each peptide has its own batch and its own Certificate of Analysis. This guide covers laboratory science only.
“CJC-1295 ipamorelin” is a common search, and the two names often sit side by side in papers and catalogues. That can make them sound like one product. They are not. This guide explains what each peptide is, how they differ, why they are studied together, and how to check the paperwork for each one. You can also watch our CJC-1295 and ipamorelin video.
1. Two peptides, one search term
CJC-1295 and ipamorelin act at two different receptors on the same type of pituitary cell. Because of that, lab studies sometimes compare them or look at them side by side. Being named together does not make them a single compound: each has its own sequence, mass and test results.
2. CJC-1295 and the “DAC” question
- What it is: a 29-amino-acid analogue of GHRH (1-29), the short active fragment of growth hormone-releasing hormone (GHRH). Four amino acids are swapped (D-Ala at position 2, Gln at 8, Ala at 15, Leu at 27) and the end of the chain is an amide. This version is also called modified GRF (1-29) or Mod GRF 1-29.
- What “DAC” means: Drug Affinity Complex. It is an extra lysine carrying a reactive group that binds to the blood protein albumin. The original CJC-1295 described in 2005 carries this DAC group [1].
- Formula and mass (no DAC): C152H252N44O42, approx. 3367.9 g/mol. The DAC form is heavier (around 3,650 g/mol).
- Why the names get mixed up: many catalogues use “CJC-1295” for the DAC-free peptide. Always check the exact form and the mass on the COA, not just the short name.
3. Ipamorelin
- What it is: a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2. Aib is aminoisobutyric acid and D-2-Nal is D-2-naphthylalanine, two building blocks not found in normal proteins.
- Formula and mass: C38H49N9O5, approx. 711.9 g/mol.
- Origin: it was described in 1998 as coming out of a chemistry programme on GHRP-1-type peptides. In rat pituitary cell assays it acted through the GHRP (ghrelin) receptor, and the authors described it as selective [2].
4. Side by side
| CJC-1295 (no DAC) | Ipamorelin | |
|---|---|---|
| Length | 29 amino acids | 5 amino acids |
| Type | GHRH (1-29) analogue | Synthetic pentapeptide (GHRP family) |
| Formula | C152H252N44O42 | C38H49N9O5 |
| Molar mass | approx. 3367.9 g/mol | approx. 711.9 g/mol |
| Receptor family studied | GHRH receptor (class B GPCR) [3] | Ghrelin receptor, GHS-R1a (class A GPCR) [4] |
| Unusual building blocks | D-Ala2, C-terminal amide | Aib, D-2-Nal, D-Phe, C-terminal amide |
| How it is tested | HPLC purity (and mass data where shown) | HPLC purity (and mass data where shown) |
5. Why they are studied together
The GHRH receptor and the ghrelin receptor are two different signalling routes on the same pituitary cells, so researchers sometimes study the two peptides side by side to compare those routes in lab models [3, 4].
6. Checking a COA for each
- Separate paperwork: each peptide should have its own batch number and its own certificate.
- Exact name: the CJC-1295 COA should name the DAC-free form (or Mod GRF 1-29).
- Mass check: where mass data are shown, they should match the calculated value (about 3368 for CJC-1295 no DAC, about 712 for ipamorelin).
- Purity and date: read the HPLC purity and the test date, and match the batch number to the label.
- Both in one vial? If a product contains both peptides, ask for documentation that covers both.
Our guides on verifying a peptide COA and reading an HPLC chromatogram walk through each step, and every published batch is on our verification page.
Frequently asked questions
Are CJC-1295 and ipamorelin the same thing?
No. CJC-1295 is a 29-amino-acid peptide and ipamorelin is a 5-amino-acid peptide. They have different sequences, masses and receptors.
What is the difference between CJC-1295 with DAC and without DAC?
The DAC form has an extra lysine with a group that binds to albumin, which makes it heavier and changes how long it lasts in lab models. The DAC-free form (Mod GRF 1-29) does not have that group. Findings on one form cannot be assumed for the other.
Is Mod GRF 1-29 the same as CJC-1295 no DAC?
Yes. They are two names for the same 29-amino-acid sequence.
Key takeaways
- CJC-1295 (no DAC) and ipamorelin are two different peptides, often named together.
- CJC-1295 no DAC: 29 amino acids, approx. 3367.9 g/mol, GHRH receptor.
- Ipamorelin: 5 amino acids, approx. 711.9 g/mol, ghrelin receptor.
- Check a separate batch number, name, mass and HPLC result for each.
- See CJC-1295 (DAC-free) research vials, Ipamorelin research vials, the CJC-1295 and ipamorelin video and the Learning Hub.
Published Research
The peer-reviewed papers below were used for the science in this article. Each entry was checked against PubMed on 9 November 2026. Summaries describe chemistry, laboratory and cell-based findings only. Corex Vitality™ is not affiliated with the cited authors, journals or institutions.
- Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Jetté L, Léger R, Thibaudeau K, et al. Endocrinology. 2005;146(7):3052-8. PMID: 15817669 · DOI: 10.1210/en.2004-1286
Identifies CJC-1295 as a GHRH (1-29) analogue carrying a Drug Affinity Complex (DAC) that binds to albumin, and reports receptor activation in laboratory pituitary cell assays. - Ipamorelin, the first selective growth hormone secretagogue. Raun K, Hansen BS, Johansen NL, et al. Eur J Endocrinol. 1998;139(5):552-61. PMID: 9849822 · DOI: 10.1530/eje.0.1390552
Describes ipamorelin as a synthetic pentapeptide from a GHRP-1 chemistry programme. In rat pituitary cell assays it acted through the GHRP (ghrelin) receptor pathway and was reported as selective relative to related peptides tested. - Structural basis for activation of the growth hormone-releasing hormone receptor. Zhou F, Zhang H, Cong Z, et al. Nat Commun. 2020;11(1):5205. PMID: 33060564 · DOI: 10.1038/s41467-020-18945-0
Reports a structural view of the human GHRH receptor (a class B GPCR) bound to a peptide agonist, showing how the receptor recognises GHRH-family ligands. - Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren. Liu H, Sun D, Myasnikov A, et al. Nat Commun. 2021;12(1):6410. PMID: 34737341 · DOI: 10.1038/s41467-021-26735-5
Reports structures of the human ghrelin receptor (GHS-R1a) with ghrelin and with a synthetic agonist, clarifying how this class A GPCR recognises peptide ligands.
All Corex Vitality™ products are supplied strictly for in-vitro laboratory research use only. Not for human or veterinary use. No information here describes use in humans or animals.

Free guide
How to read a COA
Get it by email, plus our research updates. No spam, unsubscribe any time.